Finance

Lists
301333:SHE
R&G PharmaStudies Co Ltd
CN¥55.38
+1.24%
(+0.68) 1D
Oct 30, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301333...
Open
CN¥54.30
High
CN¥59.60
Low
CN¥52.52
Mkt. cap
5.35B
Avg. vol.
2.49M
Volume
3.48M
Dividend
0.29%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jul 3, 2026
P/E ratio
45.30
52-wk high
CN¥91.78
52-wk low
CN¥43.79
EPS
CN¥1.22
Shares outstanding
96.58M
No. of employees
3K
Open
CN¥54.30
High
CN¥59.60
Low
CN¥52.52
Mkt. cap
5.35B
Avg. vol.
2.49M
Volume
3.48M
Dividend
0.29%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jul 3, 2026
P/E ratio
45.30
52-wk high
CN¥91.78
52-wk low
CN¥43.79
EPS
CN¥1.22
Shares outstanding
96.58M
No. of employees
3K
News stories
From web sources and news partners
About R&G PharmaStudies Co Ltd
CEO-
Employees2.64K
FoundedAug 22, 2008
Headquarters-
SectorHealth care
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
243.64M
218.09M
249.87M
245.83M
Cost of goods sold
164.25M
152.25M
174.53M
174.40M
Cost of revenue
164.25M
152.25M
174.53M
174.40M
Research and development expenses
16.19M
15.51M
18.39M
19.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.78M
23.05M
24.60M
24.72M
Operating expense
50.32M
39.67M
50.25M
37.74M
Total operating expenses
214.57M
191.92M
224.78M
212.14M
Operating income
29.07M
26.18M
25.09M
33.68M
Other non operating income
1.43M
-3.03M
3.02M
-9.29M
EBT including unusual items
45.33M
25.76M
24.43M
32.76M
EBT excluding unusual items
32.65M
26.20M
22.97M
30.61M
Income tax expense
3.87M
2.88M
1.95M
498.44K
Effective tax rate
8.54%
11.16%
7.97%
1.52%
Other operating expenses
1.05M
1.01M
1.30M
-820.65K
Net income
41.33M
22.83M
21.64M
30.72M
Net profit margin
16.96%
10.47%
8.66%
12.50%
Earnings per share
-
-
-
-
Interest and investment income
6.24M
3.65M
1.47M
1.17M
Interest expense
-623.36K
-605.42K
-567.67K
-1.00M
Net interest expenses
5.62M
3.05M
906.53K
168.25K
Depreciation and amortization charges
-
-
-
-
EBITDA
30.77M
27.88M
26.74M
35.39M
Gain or loss from assets sale
9.34K
-
-3.52K
3.52K
Upcoming events
AI content may include mistakes. Learn more
Google apps